Cargando…
Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widel...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534803/ https://www.ncbi.nlm.nih.gov/pubmed/31143211 |
_version_ | 1783421482869719040 |
---|---|
author | Noorbakhsh, Mohammad-Foad Shaterzadeh-Yazdi, Hanieh Hayati, Farzad Samarghandian, Saeed Farkhondeh, Tahereh |
author_facet | Noorbakhsh, Mohammad-Foad Shaterzadeh-Yazdi, Hanieh Hayati, Farzad Samarghandian, Saeed Farkhondeh, Tahereh |
author_sort | Noorbakhsh, Mohammad-Foad |
collection | PubMed |
description | Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widely investigated herbs. Thymoquinone (TQ) is the major component of the volatile oil of black seed (54%) which has been indicated to anti-oxidant, anti-inflammatory and anti-neoplastic properties. There is interesting to study on TQ effect as a therapeutic agent for various diseases in both in vivo and in vitro conditions. In this comprehensive review, we summarized the recent studies related to the effectiveness of TQ on lung disorders such as inflammatory lung diseases, lung fibrosis, asthma and lung cancer. It is concluded that TQ with anti-inflammatory, anti- oxidant, anti-asthmatic and anti- tumor activity can provide therapeutic effects against lung disorders. However, more investigation is needed to produce TQ as a pharmaceutical preparation for human studies. |
format | Online Article Text |
id | pubmed-6534803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | National Research Institute of Tuberculosis and Lung Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-65348032019-05-29 Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies Noorbakhsh, Mohammad-Foad Shaterzadeh-Yazdi, Hanieh Hayati, Farzad Samarghandian, Saeed Farkhondeh, Tahereh Tanaffos Review Article Lung as vital organ is exposed to many injurious agents that can cause inflammation and oxidative stress, which are potential causes in the pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed, has been considered for treatment of various diseases and is one the most widely investigated herbs. Thymoquinone (TQ) is the major component of the volatile oil of black seed (54%) which has been indicated to anti-oxidant, anti-inflammatory and anti-neoplastic properties. There is interesting to study on TQ effect as a therapeutic agent for various diseases in both in vivo and in vitro conditions. In this comprehensive review, we summarized the recent studies related to the effectiveness of TQ on lung disorders such as inflammatory lung diseases, lung fibrosis, asthma and lung cancer. It is concluded that TQ with anti-inflammatory, anti- oxidant, anti-asthmatic and anti- tumor activity can provide therapeutic effects against lung disorders. However, more investigation is needed to produce TQ as a pharmaceutical preparation for human studies. National Research Institute of Tuberculosis and Lung Disease 2018-10 /pmc/articles/PMC6534803/ /pubmed/31143211 Text en Copyright© 2018 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Noorbakhsh, Mohammad-Foad Shaterzadeh-Yazdi, Hanieh Hayati, Farzad Samarghandian, Saeed Farkhondeh, Tahereh Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title_full | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title_fullStr | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title_full_unstemmed | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title_short | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies |
title_sort | protective effects of thymoquinon on pulmonary disorders in experimental studies |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534803/ https://www.ncbi.nlm.nih.gov/pubmed/31143211 |
work_keys_str_mv | AT noorbakhshmohammadfoad protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies AT shaterzadehyazdihanieh protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies AT hayatifarzad protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies AT samarghandiansaeed protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies AT farkhondehtahereh protectiveeffectsofthymoquinononpulmonarydisordersinexperimentalstudies |